MIP presentationfn (1)

MR MUSABE FESTO MUSORO

Malaria in pregnancy (MIP) is a significant health concern, particularly in tropical regions like sub-Saharan Africa. Pregnant women are at increased risk due to altered immune responses, making them more susceptible to Plasmodium falciparum infections. MIP can lead to severe complications for both the mother and the fetus, including anemia, acute pulmonary edema, hypoglycemia, spontaneous abortion, preterm labor, low birth weight, and intrauterine fetal demise. Diagnosis relies on clinical features and confirmation via mRDT or blood slides, while management involves prompt treatment and prevention strategies like Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) and the use of insecticide-treated nets.